Umeclidinium/ Vilanterol

DRUG2 trials

Sponsors

GlaxoSmithKline, Boehringer Ingelheim

Conditions

Pulmonary Disease, Chronic Obstructive

Phase 2

Dose-Finding Study of Batefenterol (GSK961081) Via Dry Powder Inhaler in Patients With Chronic Obstructive Pulmonary Disease (COPD)

CompletedNCT02570165

GlaxoSmithKlinePulmonary Disease, Chronic Obstructive

Start: 2015-11-06End: 2016-07-06Updated: 2019-07-16

Unknown Phase

A Study Based on Medical Records That Looks at the Duration of Use of Two Types of Inhalers With Different Medicines in Patients With Chronic Obstructive Pulmonary Disease (COPD)

CompletedNCT03979807

Boehringer IngelheimPulmonary Disease, Chronic Obstructive

Start: 2019-06-10End: 2019-06-11Updated: 2021-11-15